ROS1 gene rearrangements occur in 1–2% of human non-small cell lung cancers and confer a distinct clinical phenotype (Bergethon et al., 2012; Gainor and Shaw, 2013). The gene discussed is ROS1; the disease is non-small cell lung carcinoma.